baber/WOPTO huggingface dataset:
Patent AU-2738900-A (AU)
Title: Methods for enhancing binding interactions between members of specific binding pairs
Inventor: RAO GALLA CHANDRA
IPC: G01N33/566
Filed: 2000-01-27
Abstract: Disclosed is a method that improves the efficiency of reactions between specific binding pairs. By translating one member of the pair through a suspension of the second member, or across a surface to which the second member is immobilized, collision and binding frequencies are greatly increased. The resulting increased binding frequency allows for reduced incubation times and lower incubation temperatures. The enhanced collisions are advantageous for both molecular reactions, in which mixing is not always effective, and cellular reactions, in which the cells may be damaged by mixing.
Patent AU-2749795-A (AU)
Title: Pharmaceutical preparation with a hydrophobic active substance and an effervescent system, and process for preparing said preparation
Inventor: GERGELY GERHARD
IPC: A61K31/4468
Filed: 1995-05-19
Abstract: PCT No. PCT/EP95/01904 Sec. 371 Date Dec. 17, 1996 Sec. 102(e) Date Dec. 17, 1996 PCT Filed May 19, 1995 PCT Pub. No. WO95/34284 PCT Pub. Date Dec. 21, 1995A pharmaceutical formulation includes a hydrophobic active substance, an effervescent system, and at least two surfactants. Each of the surfactants is selected from a different group selected from the following three groups: phospholipids, polysorbates, and esterified sugars. The formulations provide improved dispersion and bioavailability of hydrophobic active substances.
Patent AU-3083700-A (AU)
Title: A chair arrangement
Inventor: OPSVIK PETER
IPC: A47C3/02
Filed: 2000-01-03
Abstract: The present invention relates to a chair arrangement comprising a seat (1) and a back rest (2) which together form a chair body (3), and one or more supporting means, e.g. a stand (4), supporting the seat (1) and back rest (2), and for the purpose of providing a chair which provides movement and variation in a new manner it is, according to the invention, suggested that the seat (1) and back rest (2) of the chair body be attached flexibly with respect to each other by means of ropes or similar members (7, 8), and that the seat (1) and back rest (2) also be attached flexibly with respect to the supporting means or stand (4).
Patent AU-3171797-A (AU)
Title: Process to eliminate haemoglobin errors during the determination of albumin
Inventor: WEISHEIT RALPH
IPC: G01N33/68
Filed: 1997-06-02
Abstract: The invention relates to a process for determination of albumin in a sample containing free haemoglobin by optical measurement at at least two wave lengths. According to said process, (a) a measuring signal which is sufficiently high for determination is provided at a first measuring wave length; (b) (i) no measuring signal for albumin or (ii) a measuring signal for the albumin is provided at a second measuring wave length, said signal being smaller in comparison with the measuring signal at the first measuring wave length; and (c) at the first and the second measuring wave length a comparatively high interfering signal which is produced by reaction of haemoglobin with the test reagent used to determine albumin, and which changes in relation to time.
Patent AU-3207395-A (AU)
Title: Spinal support system for seating
Inventor: WALKER BROCK M
IPC: A61G15/00
Filed: 1995-08-04
Abstract: A spinal support device (10) for applying a directed and concentrated force on the sacrum to position the sacrum and pelvis to thereby establish a desired spinal posture when in a seated position. The device comprising a rigid support member (44) and a brace member (32) to which the rigid support member is attached. The device provides isolatable force on the sacrum from the sacral base line downwardly to a bottom seat surface and for a width across an individual's back approximately equal to twice the dimension of the posterior portion of the individual's sacrum. <MATH>
Patent AU-3263693-A (AU)
Title: Pharmaceutical compositions containing nifedipine and process for the preparation thereof
Inventor: TRIGGER DAVID
IPC: A61K47/32
Filed: 1993-01-12
Abstract: PCT No. PCT/GB93/00055 Sec. 371 Date Jul. 11, 1994 Sec. 102(e) Date Jul. 11, 1994 PCT Filed Jan. 12, 1993 PCT Pub. No. WO93/13773 PCT Pub. Date Jul. 22, 1993This invention relates to a slow release nifedipine-containing pharmaceutical compositions and methods of making such compositions. The compositions of the inventions comprise a soluble carrier coated with nifedipine and polyvinylpyrrolidone and an acrylic based polymer. Nifedipine is present, in amorphous form, in excess amounts to polyvinylpyrrolidone and in equal or excess amounts to the acrylic based polymer.
Patent AU-3489993-A (AU)
Title: Asphalt composition and process for obtaining same
Inventor: DUONG QUOC DINH
IPC: C08L17/00
Filed: 1993-02-23
Abstract: PCT No. PCT/CA93/00074 Sec. 371 Date Dec. 30, 1993 Sec. 102(e) Date Dec. 30, 1993 PCT Filed Feb. 23, 1993 PCT Pub. No. WO93/17076 PCT Pub. Date Sep. 2, 1993.In accordance with the present invention, there is provided an asphalt composition which incorporates asphalt in admixture with synthetic or natural rubber and a vulcanizing agent. There is also provided a process for preparing the above asphalt composition. Preferably, the rubber is obtained from waste tires or tubes.
Patent AU-3644289-A (AU)
Title: Novel derivatives, process for their preparation, intermediates and their use as medicaments
IPC: C07C333/00
Filed: 1989-06-14
Abstract: The invention relates to compounds of the general formulae (II) <IMAGE>  in which     A represents hydrogen or methyl, and B represents a group of the formula -NH, -NH-CO-, -NH-CS-, -NH-COO-, -NH-SO2- or -NH-CO-NH- or -NH-CS-NH-,   D represents oxygen or the group =NH, and   D' represents hydroxyl or the group NH2, and E represents hydrogen or, in the case of (IIa), represents hydrogen or the group =CHR<1>. By acylating the corresponding threonine derivatives by means of diketene and using the intermediates II for the preparation of the threonyl esters of 3,5-dicarboxy-1,4-dihydropyridine.
Patent AU-3682097-A (AU)
Title: Valve apparatus
Inventor: NORTH ALAN DAVID
IPC: F16K31/34
Filed: 1997-09-03
Abstract: Valve apparatus 10 For use in fluids storage vessels, the apparatus comprising an inlet for receiving a pressurised fluid to be stored in such a storage vessel, an outlet 94 for discharging said pressurised fluid into said vessel, means 82, 84 for controlling flow of said pressurised fluid between said inlet and outlet, outlet valve means 12 moveable from a flow preventing position to a flow permitting position to permit discharge of fluid stored in said vessel via an opening in said vessel, the apparatus being adapted such that, in use, discharge of said pressurised fluid from said outlet to refill said vessel is prevented until said outlet valve means has at least substantially returned to said flow preventing position. <IMAGE>
Patent AU-3695893-A (AU)
Title: Lancet device for puncturing the skin
IPC: A61B17/32
Filed: 1993-04-15
Abstract: The piercing component at its free end pointing away from the handgrip has a lancet with a pointed end for targeted introduction into the skin. The handgrip (13) is formed at least partially as a spring-elastic body in the form of a membrane (20). The membrane is formed as a plate-shaped body which in cross-section is concavely arched. The piercing component on its shaft part has projections (24,25) which work in conjunction with corresp. projections in the inner space of the bush component. <IMAGE>
Patent AU-3769289-A (AU)
Title: Condensed pyrazole 3-oxo-propanenitrile derivatives and process for their preparation
Inventor: DORIA GIANFEDERICO
IPC: C07D231/54
Filed: 1989-06-16
Abstract: Condensed pyrazole 3-oxo-propanenitrile derivatives of formula (I)   <CHEM> wherein X represents a - CH(R4)-group, an oxygen atom or a - S(O)n- group where n is 0, 1 or 2; R1 represents C1-C6 alkyl, pyridyl or unsubstituted or substituted phenyl; R2, R3 and R4 are as defined herein; and Q represents hydrogen, carboxy, C2-C7 alkoxycarbonyl or a - CON(Ra)Rb group, Ra and Rb being as defined herein; and their pharmaceutically acceptable salts have immunomodulating activity and can be used in particular as immunostimulating agents, e.g. in the treatment of acute and chronic infections of both bacterial and viral origin, alone or in association with antibiotic agents, and in the treatment of neoplastic diseases, alone or in association with antitumoral agents, in mammals.
Patent AU-3807797-A (AU)
Title: The NucA protein of haemophilus influenzae and the gene encoding that protein
Inventor: ZAGURSKY ROBERT JOHN
IPC: A61K47/42
Filed: 1997-07-23
Abstract: A protein from H. influenzae designated NucA is isolated and purified. The NucA protein has the amino acid sequence of amino acids 26-603 of SEQ ID NO.2 or a biologically equivalent amino acid sequence thereof. Amino acids 1-25 of SEQ ID NO.2 are the signal peptide, which is cleaved during processing of the mature protein. The NucA protein has a molecular weight of approximately 63,000 Daltons as measured on a 12% SDS-PAGE gel and possesses 5'-nucleotidase activity. The NucA protein is obtained by isolation and purification from the H. influenzae organism, by chemical synthesis or by recombinant expression by an isolated and purified nucA DNA sequence which encodes the NucA protein. Such a DNA sequence hybridizes under standard high stringency Southern hybridization conditions with a DNA sequence encoding the NucA protein of H. influenzae having the amino acid sequence of amino acids 26-603 of SEQ ID NO.2 or a biologically equivalent amino acid sequence thereof. The NucA protein is used to prepare a vaccine composition which elicits a protective immune response in a mammalian host to protect the host against disease caused by H. influenzae.
Patent AU-3883593-A (AU)
Title: An optimal dc motor/controller configuration
Inventor: LANKIN ROBERT
IPC: H02P7/298
Filed: 1993-03-30
Abstract: Optimal constructions for two motor/controller configurations are disclosed. The controller structure includes an H-bridge for controlling field current using synchronous-rectification of MOSFET devices, and a circuit for chopping the armature current using synchronous-rectification of MOSFET devices arranged in a half bridge. The controller may be configured with a series-wound or a separately excited DC traction motor. In the series-wound motor/controller configuration, the field and the armature current are separately controlled. In the separately excited motor/controller configuration, the field of the motor is preferably wound so that the rated field current is achieved at about 20% of the rated battery voltage. This provides a separately excited motor in which the field current can be boosted by a factor of 5 to achieve high start-up and low speed torques which match the torque outputs of a series-wound motor under similar operating conditions.
Patent AU-3941002-A (AU)
Title: Cyp1b1 nucleic acids and methods of use
Inventor: AZIZ NAZNEEN
IPC: A61K48/00
Filed: 2001-10-31
Abstract: The present invention provides nucleic acids containing transcriptional units that encode CYP1B1 I polypeptides or portions thereof, wherein the transcriptional units lack sequences found in the untranslated region (UTR) or naturally occurring forms of the CYP1B1 transcript. Then nucleic acids of the invention lack transitional repressor elements and thus provide for a system of enhanced translation of the CYP1B1 polypeptide or portions thereof. Also disclosed are methods of administering nucleic acids to a mammal and use in the treatment of proliferative disorders or cancers.
Patent AU-4002893-A (AU)
Title: Cooling method and apparatus
Inventor: LEE RON C
IPC: F25D3/10
Filed: 1993-06-03
Abstract: A method and apparatus for cooling a heat load in which a pressure vessel (16) is provided to contain a cryogen as a saturated liquid (18) and saturated vapour (20) separated by liquid-vapour interface (22). The pressure vessel (16) has an inlet (24) adapted to receive a subcooled liquid cryogen and thereby convert it to a saturated liquid (18) through contact with the saturated vapour (20). A heated overflow tube (26) projects into the pressure vessel (16) and is level, at one end, with the liquid-vapour interface (22) so that any increase in the saturated liquid overflows into overflow tube (26) and is vaporised to form the saturated vapour (20). The heat transfer and the re-introduction of the vaporised liquid can be effected through forced circulation provided by an ejector (32 or 34). Preferably the pressure vessel (16) is provided with two outlets (28,30) for discharging the saturated cryogen as saturated liquid or vapour. One or more ejectors (32 or 34) having high pressure inlet(s) (42 or 46) in communication with the two outlets (28,30) of the pressure vessel (16) are provided for drawing the heat transfer fluid, after having cooled the heat load, into a heat transfer relationship with the overflowed saturated liquid and then into mixture(s) with the saturated liquid or saturated vapour, or both and for discharging the same out of a high pressure outlet of the ejector to the heat load. <IMAGE>
Patent AU-4375389-A (AU)
Title: Pyrrolidine derivatives
Inventor: SETOI HIROYUKI
IPC: A61K31/425
Filed: 1989-10-26
Abstract: A compound of the formula : <CHEM>  wherein R<1> is alkyl, ar(lower)alkyl which may have suitable substituent(s), or heterocyclic(lower)alkyl,  R<2> is hydrogen or an acyl group, and R<3> is carboxy(lower)alkyl, protected carboxy(lower)alkyl, carboxyaryl or protected carboxyaryl,  and a pharmaceutically acceptable salt thereof, processes for their preparation and pharmaceutical compositions comprising them or a pharmaceutically acceptable salt thereof in admixture with pharmaceutically acceptable carriers.
Patent AU-4637399-A (AU)
Title: Method of reducing or preventing malodour
Inventor: BEHAN JOHN MARTIN
IPC: A61Q13/00
Filed: 1999-07-06
Abstract: A method of reducing or preventing body malodour by topically applying to human skin perfume components capable of inhibiting the producation of odoriferous steroids by microorganisms on the skin. The perfume components are capable of inhibiting bacterial 4-ene reductase and/or 5alpha-reductase.
Patent AU-4908799-A (AU)
Title: Determination of the hydrophobic pulmonary surfactant protein sp-c
Inventor: ISE WOLFGANG
IPC: C12P21/08
Filed: 1999-07-08
Abstract: Methods for determining the strongly hydrophobic pulmonary surfactant protein SP-C, SP-C specific antibody and a reagent kit for carrying out the methods are described.
Patent AU-5053885-A (AU)
Title: Lavatory cleansing blocks
Inventor: BARFORD ERIC DENNIS
IPC: C11D1/14
Filed: 1985-11-29
Abstract: A lavatory cleaning block is formed of a mixture comprising:(a) from 5 to 85% by weight of one or more anionic surface active agents;(b) from 2 to 50% by weight of one or more solubility control agents having a solubility in water less than that of the anionic surface active agent(s); and(c) from 0.5 to 50% by weight of one or more water-soluble salts of polyvalent metals;
Patent AU-5067599-A (AU)
Title: Rna virus vector having contact infiltration capability
Inventor: ASAKAWA MAKOTO
IPC: C12N15/86
Filed: 1999-08-10
Abstract: The present invention provides an RNA virus vector useful for gene therapy. The RNA virus vector is capable of cell infection, autonomous RNA replication, and infiltration through contact, but incapable of dessimination. The use of the RNA virus vector of the present invention enables more efficient gene transfer and cell transplantation in gene therapy compared with the conventional techniques. <IMAGE>
Patent AU-5200596-A (AU)
Title: Method and apparatus for contact lens mold filling and assembly
Inventor: MARTIN WALLACE ANTHONY
IPC: B29D11/02
Filed: 1996-05-01
Abstract: An apparatus for forming contact lenses, wherein front curve mold halves are filled with a hardenable transparent material, such as a polymerizable hydrogel, and back curve mold halves are coupled to the front curve, therein forming a lens. More Particularly, the apparatus includes a conveyor means for transporting pallets of mold halves to the apparatus, an array of piston structures for raising and aligning the back curves with respect to the filled front curve halves, reciprocating means for reciprocating the piston array to couple pairs of front and back curves, and a vacuum chamber and vacuum drawing means for maintaining a vacuum around the curves during coupling. In addition, there is provided individual spring biasing to each reciprocating element whereby sensitivity to thickness variations and pallet misfeeds may be minimized. Further, there is provided a vacuum sleeve, through which the pistons reciprocate within the vacuum chamber, which sleeve preserves the vacuum within the chamber.
Patent AU-5216686-A (AU)
Title: Bile-sustituting pharmaceutical composition for promotion of fat digestion and a process for its preparation
Inventor: SZEJTLI JOZSEF
IPC: C08B37/16
Filed: 1986-01-09
Abstract: The invention relates to a method of promoting the fat digestion and absorption, which comprises orally administering to an animal subject a partially methylated- beta -cyclodextrin optionally together with pharmaceutically acceptable auxiliary and/or additive materials.
Patent AU-5542894-A (AU)
Title: Humanized antibodies to fc receptors for immunoglobulin g on human mononuclear phagocytes
Inventor: TEMPEST PHILIP R
IPC: C12R1/91
Filed: 1993-11-04
Abstract: Humanized antibodies are described which are specific to an Fc receptor (FcR). The humanized antibodies have at least a portion of a complementarity determining region (CDR) derived from a non-human antibody, e.g., murine, with the remaining portions being human in origin. The humanized antibodies can be used therapeutically as is or formulated as bifunctional molecules or immunotoxins.
Patent AU-5572380-A (AU)
Title: Spiral type one-way clutch assembly
Inventor: KERR JOHN HUGH
IPC: F16D41/08
Filed: 1980-02-20
Abstract: A spiral type one way clutching assembly and mechanism is provided herein which is insensitive to transverse forces; substantially eliminates overrunning frictional wear on the critically shaped surfaces of its members; and substantially eliminates the role of chance in establishing the clutching load distribution between its members. The clutching mode may be active or passive. The clutching mechanism utilizes monolithic annular outer and concentrically positioned annular inner body members which have mutually opposed tangentially congruent spiral surfaces defining a spiral race therebetween. The spiral race is provided with inner and outer abutments. At least one of the inner and the outer body members have a radially directed slit extending therethrough. The outer body member and the inner body member are relatively rotatably oscillatable with respect to each other. A plurality of axially oriented abutting roller members is positioned in, an almost fills, the spiral race, each such member being in contact with the inner and the outer spiral surfaces. Limit springs act between the body members for limiting the relative oscillatory movement therebetween.
Patent AU-5754094-A (AU)
Title: Electrochemiluminescent assays
Inventor: MASSEY RICHARD J
IPC: C07K16/00
Filed: 1994-03-02
Abstract: Novel compounds for use in electrochemiluminescent assays and characterised by containing the structure        X - Y - ZwhereinX represents one or more nucleotides which may be the same or different, one or more amino acids which may be the same or different, an antibody, an analyte of interest or an analogue of an analyte of interestY represents a linker group attached to X and Z,andZ represents an electrochemiluminescent moiety, and intermediates employed in their synthesis.
Patent AU-5841086-A (AU)
Title: Self-unloading train for bulk commodities
Inventor: SNEAD EDWIN DESTEIGER
IPC: E01B27/02
Filed: 1986-06-05
Abstract: A unit train consists of a plurality of hopper cars (11, 12, 13) and a multi-purpose trailer car (15). The hopper cars (11, 12, 13) have one or more hoppers (21) each having a bottom discharge opening (31) and a controllable gate (32). An endless belt conveyor (40) traverses the length of the train including a portion of the trailer car (15), and underlies the hopper discharge gates (32) so that the hoppers (21) may be emptied sequentially onto the train conveyor (40) to unload the entire train. The trailer car (15) includes a lift portion (45) of the train conveyor (40) to elevate the material for discharge onto a transfer conveyor (50) carried on the trailer car (15). The elongated transfer conveyor (50) is pivotally mounted (51) at the receiving end to be swung laterally to discharge the material received from the train conveyor (40) at some selected point alongside the track. The trailer car (15) may include the power system and control system for operating the conveyors (40, 50) and the hopper gates (32). The train is self-unloading by depositing the train load in a windrow alongside the track while the train is moving slowly. For unloading the train in a stationary position, the transfer conveyor (50) may deposit the material onto a portable stacking conveyor (60) which may then deposit the entire train load in one or more stockpiles which may be thirty feet (9 meters) high and located some distance from the track.
Patent AU-6124300-A (AU)
Title: Non-beta-oxidizable fatty analogues, their uses as therapeutic active medicaments, and preparation thereof
Inventor: BERGE ROLF
IPC: A61P3/06
Filed: 2000-09-21
Abstract: Use is disclosed of non-β-oxidizable fatty acids analogues of the general formula (I)         Alkyl-X-CH<sub>2</sub>COORwherein alkyl represents a saturated or unsaturated hydrocarbon group of from 8-26 carbon atoms, X represents a sulphur atom and R is hydrogen or C<sub>1</sub>-C<sub>4</sub> alkyl, for the manufacture of a medicament to reduce the growth of cancer cells.
Patent AU-6249190-A (AU)
Title: Preservative for ophthalmic solutions
IPC: A61K9/00
Filed: 1990-09-13
Abstract: An ophthalmic formulation comprising a salt of sepazonium or a similar imidazolium compound as a preservative is provided.
Patent AU-6314996-A (AU)
Title: Recombinant poxvirus-rabies compositions and combination compositions and uses
Inventor: PAOLETTI ENZO
IPC: C07K14/065
Filed: 1996-06-03
Abstract: Attenuated recombinant viruses containing DNA encoding a rabies virus antigen in a "cocktail" or combination or multivalent compositions well as methods for making and using the compositions, expression products therefrom, and antibodies generated, are disclosed and claimed. The recombinant viruses can be NYVAC or ALVAC recombinant viruses. The compositions and products therefrom and antibodies generated have several preventive, therapeutic and diagnostic uses.
Patent AU-6400590-A (AU)
Title: Automatic track control
Inventor: ZUCKER FRIEDHELM
IPC: G11B7/09
Filed: 1990-09-21
Abstract: The invention concerns an optical scanning device which scans the frequency-warbled data tracks of a recording medium, the scanning light beam being reflected from the recording medium on to a four-quadrant photodetector (PD) with four photodiodes (A, B, C, D). The outputs of all four photodiodes (A, B, C, D) are added in an addition amplifier (V2). In order to be able to compensate automatically for offset voltages produced in the focussing-control loop by, for instance, temperature fluctuations, the output of the addition amplifier (V2) is connected to one input of a multiplier (M) to whose other input the track error signal is fed. The multiplier output is fed through a low-pass filter (TP) and as a compensation voltage to the focussing-control loop.